Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) October 20, 2011 -- The API market revenues in the Americas are expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2010 to 2015. As the North American pharmaceutical market recovers from the impacts of economic downturn, API market revenues are expected to witness steady growth.The faster growing markets of South and Central America will provide a greater contribution to the overall growth of the API market in the Americas. Brazil in particular is witnessing very strong growth in pharmaceuticals and API market revenues and is expected to overtake Mexico in the coming years.

The American pharmaceutical and API market has been historically dominated by the branded sector. However, the growth pattern is rapidly changing. As a consequence of the impact of the global economic slowdown on some of the major American economies, the expenditure on research and innovation is controlled to some extent. Due to this, the growth of the branded sector of the API market has been impacted. On the other hand, the generic API sector is witnessing strong growth. This is mostly because of the patent expiries of some of the major branded drugs as well as healthcare cost containment measures. Generic sector APIs are expected to hold an increased share of the overall API market in the Americas by 2015.

For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Active-Pharmaceutical-Ingredients-%28APIs%29-in-the-Americas-Market-to-2016-Growth-in-Biotechnology-and-Generic-Segments-and-the-Pharmaceutical-Patent-Cliff-will-Shape-the-Landscape&Title=Chemicals&ReportType=Industry_Report&CompanyID=fprco

As the US has been the world’s largest pharmaceutical market historically, it has a dominating share of the Americas’ API market revenues. Growth rates are expected to be higher in the markets of South and Central America than those in the North American market. Brazil is the fastest growing market in the region, and the country is expected to hold a significantly increased share of the Americas’ market revenue by 2015.

GBI Research’s report, “Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape”, provides a detailed insight into the American API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in the Americas. The report contains market forecasts, product type analysis, drivers and restraints, and details of the competitive landscape of major producers in the region. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and SWOT analysis of the API markets in the major countries of the region. Overall, the report presents a comprehensive analysis of the American API market, covering all the major parameters. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Active-Pharmaceutical-Ingredients-%28APIs%29-in-the-Americas-Market-to-2016-Growth-in-Biotechnology-and-Generic-Segments-and-the-Pharmaceutical-Patent-Cliff-will-Shape-the-Landscape&ReportType=Industry_Report&Title=Chemicals&CompanyID=fprco

Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299

+44 1204 543 533
Asia Pacific: +91 40 6616 6782

active pharmaceutical ingredie     APIs     chemicals